Pharmaceuticals Thailand

Thailand Contraceptive Innovations Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Thailand Contraceptive Innovations Market Industry Trends and Forecast to 2034: Segmented by (Product, Hormone, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Thailand · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $6.0 Mn Placeholder estimate
Estimate 2025 $6.4 Mn 0.1% of the global market
Projected 2034 $10.7 Mn 67.5% Adds $4.3 Mn over 9 forecast years
CAGR 2025–2034 5.9% Faster than 20% of 180 Pharmaceuticals markets here
Key players 6 +1
  • Thailand is 0.14% of the global market.
  • In APAC, the largest is China at $350.4 Mn.
  • Fastest growing: India at 8.7% a year.
  • Thailand ranks 9th of 10 by size in APAC.

Market size projection

Thailand

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$4.3 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Contraceptive Innovations Market market size by year, Thailand
YearMarket sizeChange that yearSince 2025
2024 (estimate) $6.0 Mn — —
2025 (base) $6.4 Mn +$0.4 Mn —
2026 (forecast) $6.8 Mn +$0.4 Mn +5.9%
2027 (forecast) $7.2 Mn +$0.4 Mn +12.1%
2028 (forecast) $7.6 Mn +$0.4 Mn +18.8%
2029 (forecast) $8.0 Mn +$0.4 Mn +25.8%
2030 (forecast) $8.5 Mn +$0.5 Mn +33.2%
2031 (forecast) $9.0 Mn +$0.5 Mn +41.1%
2032 (forecast) $9.5 Mn +$0.5 Mn +49.4%
2033 (forecast) $10.1 Mn +$0.6 Mn +58.2%
2034 (forecast) $10.7 Mn +$0.6 Mn +67.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Thailand Contraceptive Innovations Market Analysis at a glance
Market size, 2025$6.4 Mn placeholder estimate
Forecast, 2034$10.7 Mn placeholder estimate
Growth (CAGR), 2025–20345.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, hormone and end user (see all)
Key playersBayer AG, Organon, Perrigo Company plc, Evofem Biosciences, Mithra Pharmaceuticals and 1 more (see all)
Regulator in ThailandThai FDASource: Thai Food and Drug Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Thailand Contraceptive Innovations Market Analysis Executive Summary

Contraceptive innovations are newer birth-control options such as hormone-free gels, long-acting injectables, vaginal rings and over-the-counter pills.

Key segments of the contraceptive Innovations market include product (Over-the-Counter Pills, Long-Acting Injectables and Vaginal Rings) and hormone (Hormonal and Non-Hormonal).

Bar chart: Thailand Contraceptive Innovations market size, 2024–2034, placeholder estimates. $6.0 Mn in 2024, $6.4 Mn in 2025 and $10.7 Mn in 2034, 5.9% CAGR.
Thailand Contraceptive Innovations market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Thailand Contraceptive Innovations Market Dynamics

Market Growth Drivers

Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the contraceptive Innovations market. New products designed around women's biology and digital care are improving access.

Opportunity

Femtech, personalised care and new treatments for under-served conditions open strong growth for the contraceptive Innovations market, especially as employers and payers add women's health benefits.

Market Restraints

Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the contraceptive Innovations market.

Competitive Landscape for Contraceptive Innovations Market in Thailand

The contraceptive Innovations market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Contraceptive Innovations Market in Thailand

Contraceptive Innovations in Thailand: rules, payment and health figures

Medicines need registration with the Thai Food and Drug Administration (Thai FDA).⁠[1] The Universal Coverage Scheme, run by the National Health Security Office (NHSO), covers people outside the social security and civil servant schemes.⁠[2] Contraception use: 73% of married women 15–49 in 2022, the latest WHO figure for Thailand.⁠[3]

[1] Thai Food and Drug Administration. Checked 14 Nov 2026.

[2] National Health Security Office. Checked 14 Nov 2026.

[3] WHO Global Health Observatory, Contraception use (% of married women 15–49). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for contraceptive Innovations. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Thailand.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Contraceptive Innovations right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Contraceptive Innovations in context

Thailand compared

  • Contraception use: 73% of married women 15–49 (2022). 2nd highest of the 14 countries we cover in APAC.[1]
  • Health spending per person: 327 US$ per person (2023). World: 1,317 US$ per person (2023). 7th highest of the 15 countries we cover in APAC.[2]
  • Doctors: 0.54 per 1,000 people (2021). World: 1.86 per 1,000 people (2022). 13th highest of the 15 countries we cover in APAC.[3]

[1] World Bank Open Data, Contraception use (% of married women 15–49). Retrieved 15 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Contraceptive Innovations market in Thailand?
Placeholder estimate: about $6.4 Mn in 2025, rising to about $10.7 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Contraceptive Innovations market in Thailand growing?
Placeholder estimate: about 5.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Contraceptive Innovations market report cover?
The report splits the market by product (Over-the-Counter Pills, Long-Acting Injectables, Vaginal Rings, Non-Hormonal Gels and more), hormone (Hormonal, Non-Hormonal) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Contraceptive Innovations market?
Key players include Bayer AG, Organon, Perrigo Company plc, Evofem Biosciences, Mithra Pharmaceuticals and TherapeuticsMD.
What is driving the Contraceptive Innovations market?
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the contraceptive Innovations market. New products designed around women's biology and digital care are improving access.
Who regulates Contraceptive Innovations in Thailand?
Medicines need registration with the Thai Food and Drug Administration (Thai FDA). Source: Thai Food and Drug Administration. Checked 14 Nov 2026.
How is healthcare paid for in Thailand?
The Universal Coverage Scheme, run by the National Health Security Office (NHSO), covers people outside the social security and civil servant schemes. Source: National Health Security Office. Checked 14 Nov 2026.
What does WHO report for Thailand?
Contraception use: 73% of married women 15–49 in 2022, the latest WHO figure. Source: WHO Global Health Observatory, Contraception use (% of married women 15–49). Retrieved 15 Nov 2026.
How many people in Thailand are 65 or older?
16.0% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 15 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in Thailand

See all

Related on contraception and women's health

See the topic